| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Revenue | $831K | +979.9% |
| Cost of Revenue | $726K | +1473.2% |
| Gross Profit | $105K | +239.9% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $2.1M | +539.0% |
| Operating Income | -$2.2M | -281.4% |
| Pre-tax Income | -$2.2M | -212.1% |
| Income Tax | $0 | — |
| Net Income | -$2.2M |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9K | +263.6% |
| Current Assets | $272K | — |
| Total Assets | $280K | +7041.1% |
| Current Liabilities | $1.5M | +53.1% |
| Total Liabilities | $1.5M | +53.1% |
| Stockholders' Equity | -$1.2M | -24.4% |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$157K | -83.1% |
| Capital Expenditures | $9K | — |
| Investing Cash Flow | -$9K | -198.2% |
| Financing Cash Flow | $170K | +65.0% |
| Free Cash Flow | -$166K | -94.2% |
| -212.1% |
| EPS (Basic) | -$0.10 | — |
| EPS (Diluted) | -$0.10 | — |